CN1190218C - Chinese medicine for treating hyperosteogeny - Google Patents
Chinese medicine for treating hyperosteogeny Download PDFInfo
- Publication number
- CN1190218C CN1190218C CNB021252521A CN02125252A CN1190218C CN 1190218 C CN1190218 C CN 1190218C CN B021252521 A CNB021252521 A CN B021252521A CN 02125252 A CN02125252 A CN 02125252A CN 1190218 C CN1190218 C CN 1190218C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- root
- parched
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a traditional Chinese medicine for treating hyperosteogeny, which comprises the following components of chain fern, prepared rhizome of rehmannia, common clubmoss herb, radix dipsaci from Sichuan of China, rhizome drynaria, fructus psoraleae, mornda root, ledebouriella root, incised notoptetygium rhizome or root, doubleteeth pubesscent angelica root, parched Yimi, hemlock parsley, angelica, liquorice root, epimedium herb, parched largehead atractylodes rhizome, cassia bark, clematis root, parched Cangshu, eupolyphaga, wild ginger, stir-frying cape, frankincense and myrrh according to a proportion of 30:15:15:15:15:12:12:12:12:12:12:10:10:10:10:10:10:10:10:10:6:6:6:6. The present invention has the efficiencies of nourishing kidney and strengthening Yang, strengthening tendons and bones and activating blood circulation to dissipate blood stasis, and has an obvious effect on treating the hyperosteogeny.
Description
Affiliated technical field
The invention belongs to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is a kind of commonly encountered diseases, it is divided into inside hypertrophy and outside two kinds of hypertrophy, has physiologically, and pathology is also arranged.Physiological as: skeleton is aging, the unrest of endocrine wadding, hormonal imbalance etc.; Pathology as: because overworked, myotasis, skeleton excessive wear for a long time, local pressure stimulates periosteum and osseous tissue, causes hemorrhage, edema, metabolite in local accumulation, thereby produces this disease.In addition, easypro this disease that also produces of meridians because the deficiency of the kidney bone declines.The Chinese medicine of existing treatment hyperosteogeny is a lot, but curative effect is very little, can not eradicate, and brings the big misery of tool to the patient.
Summary of the invention
The present invention's purpose is to provide a kind of new drug for the treatment of hyperosteogeny, and it is according to motherland's medical theory, differentiation of symptoms and signs to identify etiology, and the legislation of identifying and correcting, effect is remarkable.
For reaching above-mentioned purpose, the present invention is made by following materials of weight proportions: 30 parts of Rhizoma Cibotii, 15 parts in Radix Rehmanniae Preparata, 15 parts of Herba Lycopodiis, 15 parts of Radix Dipsaci, 15 parts of Rhizoma Drynariae, 12 parts of Fructus Psoraleae, 12 parts of Radix Morindae Officinaliss, 12 parts of Radix Saposhnikoviaes, 12 parts of Rhizoma Et Radix Notopterygiis, 12 parts of Radix Angelicae Pubescentiss, fry 12 parts of Semen Coiciss, 10 parts of Rhizoma Chuanxiongs, 10 parts of Radix Angelicae Sinensis, 10 parts in Radix Glycyrrhizae, 10 parts of Herba Epimedii, 10 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 10 parts of Cortex Cinnamomis, 10 parts of Radix Clematidis, 10 parts of Rhizoma Atractylodis (parched), 10 parts of Eupolyphaga Seu Steleophagas, 6 parts of Herba Asaris, process 6 parts of Squama Manis, 6 parts of 6 parts of Olibanum (processed with vinegar) and Myrrha (processed with vinegar).
The present invention takes technique scheme, has following tangible beneficial effect, and the effect that each component has in the side is:
Rhizoma Cibotii: warm in nature, invigorating the liver and kidney, strong waist knee joint removes rheumatism;
Radix Rehmanniae Preparata: blood enriching and generation of vital essence promoting, nourishing the kidney and liver nourish heart, replenishing essence marrow, promoting blood circulation;
Herba Lycopodii: the relaxing muscles and tendons and activating QI and blood in the collateral wind-damp dispelling of holding concurrently;
Radix Dipsaci: invigorating the liver and kidney, reuniting the fractured tendons and bones, promoting blood circulation, sharp joint, strengthening bone and muscle;
Rhizoma Drynariae: the bone poisoning wind of dispelling, control flaccidity syndrome and arthralgia syndrome fracture, and can hard kidney teeth consolidating;
Fructus Psoraleae: warming the kidney to activate YANG, bone and muscle strengthening;
Radix Morindae Officinalis: kidney-replenishing, it is cold to dispel the wind, bone and muscle strengthening, benefiting essence and marrow;
Radix Saposhnikoviae: wind-damp dispelling, control the ailment said due to cold or exposure of kindred;
Rhizoma Et Radix Notopterygii: expelling wind and dampness rises the yang-energy in sun footpath and governor vessel footpath;
Radix Angelicae Pubescentis: expelling wind and dampness, analgesia, arthritis;
Fry Semen Coicis: the spleen invigorating dehumidifying;
Rhizoma Chuanxiong: promoting flow of QI and blood, dampness is searched wind, and dissipating depression of QI is transferred liver;
Radix Angelicae Sinensis: promoting blood circulation to remove obstruction in the collateral, dissipating blood stasis for subsidence of swelling;
Radix Glycyrrhizae: spleen reinforcing, heat clearing away, detoxifcation, emergency, hundred medicines are concocted in lung moistening;
Herba Epimedii: kidney invigorating and YANG supporting, bone and muscle strengthening, wind-damp dispelling;
Rhizoma Atractylodis Macrocephalae (parched): the spleen strengthening and damp drying, QI invigorating and blood producing;
Cortex Cinnamomi: warming and recuperating the kidney-YANG, a surname leads blood vessels;
Radix Clematidis: wind-damp dispelling, its property is apt to away, nowhere less than;
Rhizoma Atractylodis (parched): invigorating spleen to remove dampness;
Eupolyphaga Seu Steleophaga: the blood stasis of living, reuniting the fractured tendons and bones;
Herba Asari: scurry out stagnant, the mediation joint, control the wind and cold arthralgia pain;
Process Squama Manis: the meridian dredging, the blood stasis of living, the pain that disappears is swollen;
Olibanum: promoting flow of QI and blood, the meridian dredging;
Myrrha: dissipating blood stasis blood, subduing swelling and relieving pain;
The present invention has kidney invigorating and YANG supporting, bone and muscle strengthening, and blood circulation promoting and blood stasis dispelling, expelling wind and cold, promoting the flow of QI in the collateral by warming the meridian, the effect of invigorating spleen to remove dampness, evident in efficacy to neck lumbar vertebra hyperosteogeny and each position hypertrophy, the wet lumbago and skelalgia of wind and cold.
Olibanum and Myrrha adopt vinegar system in the prescription of the present invention, and above-mentioned each component is ground and is smalls, and it is better to be by the Mel refining that ball is taken, and every ball weighs 10 grams, and days oral three times, each ball.
The specific embodiment
Batching: 30 gram Rhizoma Cibotii, 15 gram Radix Rehmanniaes Preparata, 15 gram Herba Lycopodiis, 15 gram Radix Dipsaci, 15 gram Rhizoma Drynariae, 12 gram Fructus Psoraleae, 12 gram Radix Morindae Officinaliss, 12 gram Radix Saposhnikoviaes, 12 gram Rhizoma Et Radix Notopterygiis, 12 gram Radix Angelicae Pubescentiss, 12 grams fry Semen Coiciss, 10 gram Rhizoma Chuanxiongs, 10 gram Radix Angelicae Sinensis, 10 gram Radix Glycyrrhizaes, 10 gram Herba Epimedii, 10 gram Rhizoma Atractylodis Macrocephalae (parched)s, 10 gram Cortex Cinnamomis, 10 gram Radix Clematidis, 10 gram Rhizoma Atractylodis (parched), 10 gram Eupolyphaga Seu Steleophagas, 6 gram Herba Asaris, 6 grams process Squama Manis, 6 gram Olibanum (processed with vinegar), 6 the gram Myrrha (processed with vinegar); Grind to behind the smalls, add 400 gram Mel refinings and be ball, every ball weighs 10 grams.
Claims (1)
1. Chinese medicine for the treatment of hyperosteogeny, it is characterized in that: this Chinese medicine is to be made by following materials of weight proportions: 30 parts of Rhizoma Cibotii, 15 parts in Radix Rehmanniae Preparata, 15 parts of Herba Lycopodiis, 15 parts of Radix Dipsaci, 15 parts of Rhizoma Drynariae, 12 parts of Fructus Psoraleae, 12 parts of Radix Morindae Officinaliss, 12 parts of Radix Saposhnikoviaes, 12 parts of Rhizoma Et Radix Notopterygiis, 12 parts of Radix Angelicae Pubescentiss, fry 12 parts of Semen Coiciss, 10 parts of Rhizoma Chuanxiongs, 10 parts of Radix Angelicae Sinensis, 10 parts in Radix Glycyrrhizae, 10 parts of Herba Epimedii, 10 parts of Rhizoma Atractylodis Macrocephalae (parched)s, 10 parts of Cortex Cinnamomis, 10 parts of Radix Clematidis, 10 parts of Rhizoma Atractylodis (parched), 10 parts of Eupolyphaga Seu Steleophagas, 6 parts of Herba Asaris, process 6 parts of Squama Manis, 6 parts of 6 parts of Olibanum (processed with vinegar) and Myrrha (processed with vinegar).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021252521A CN1190218C (en) | 2002-07-19 | 2002-07-19 | Chinese medicine for treating hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021252521A CN1190218C (en) | 2002-07-19 | 2002-07-19 | Chinese medicine for treating hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1468608A CN1468608A (en) | 2004-01-21 |
| CN1190218C true CN1190218C (en) | 2005-02-23 |
Family
ID=34142815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021252521A Expired - Fee Related CN1190218C (en) | 2002-07-19 | 2002-07-19 | Chinese medicine for treating hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1190218C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1301115C (en) * | 2004-05-24 | 2007-02-21 | 池宝传 | Medicine for hyperosteogeny and its preparation |
| CN100423744C (en) * | 2004-12-23 | 2008-10-08 | 张生全 | Medication for treating hyperosteogeny and complicating disease |
| CN100420478C (en) * | 2006-04-21 | 2008-09-24 | 代北仓 | A medicine for treating hyperosteogeny and preparation method thereof |
| CN101244135B (en) * | 2008-03-27 | 2010-08-18 | 王志富 | Medicine label for treating rheumatism, hyperosteogeny |
| CN104208257A (en) * | 2013-11-20 | 2014-12-17 | 朱亶斌 | Muscle and bone pain relieving pill |
| CN103751481B (en) * | 2014-01-23 | 2016-02-17 | 胡伟 | One treats talalgia Chinese medicine for oral administration |
| CN104435471A (en) * | 2015-01-01 | 2015-03-25 | 张来意 | Traditional Chinese medicine powder for treating hypertrophic osteoarthropathy |
-
2002
- 2002-07-19 CN CNB021252521A patent/CN1190218C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1468608A (en) | 2004-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1857541A (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN1966003A (en) | Externally applied medicament for treating rheumatism | |
| CN1876084A (en) | Ointment for orthopedics | |
| CN1742979A (en) | Chinese medicine for treating proliferation of mammary gland | |
| CN105664092A (en) | Bone disease treating Hui-nationality medicinal liquor for external use | |
| CN1278446A (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN1190218C (en) | Chinese medicine for treating hyperosteogeny | |
| CN1876156A (en) | Chinese medicinal ointment for treating bones and tendons injury pain | |
| CN1606996A (en) | Plaster for traumatic injuries | |
| CN101703662B (en) | Oral Chinese medicament for treating hyperosteogeny | |
| CN1201691A (en) | Medicine for curing encephalatrophy and preparation thereof | |
| CN1502349A (en) | Traditional Chinese medicine composition (Bushenzhuangyao Decoction) for reinforcing kidney and strengtening lumbar | |
| CN101040949B (en) | Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and application | |
| CN1238018C (en) | Plaster for treating pain in neck, shoulder, waist and lower extremities | |
| CN101138625A (en) | Chinese medicine composition for treating omarthritis | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN1136899C (en) | Chinese medicine for treating mastoplasia | |
| CN102319339B (en) | Chinese medicinal composition for treating senile fracture | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1242761C (en) | Numbness-activating blood-circulation-promoting pain-relieving ointment | |
| CN1270768C (en) | Medicine for treating cold disease | |
| CN102018815A (en) | Chinese medicine preparation for treating tuberculosis of lumbar spine | |
| CN101284087B (en) | Medicinal composition for curing lumbar disease | |
| CN1160096C (en) | Numbness- and pain-eliminating capsule and preparing method thereof | |
| CN1060076C (en) | Gucixiao pill for removing spur |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |